Clinical pathway of COVID-19 patients in primary health care in 30 European countries: Eurodata study

Autores da FMUP
Participantes de fora da FMUP
- Ares-Blanco, S
- Guisado-Clavero, M
- Del Rio, LR
- Larrondo, IG
- Fitzgerald, L
- Adler, L
- Assenova, R
- Bakola, M
- Bayen, S
- Brutskaya-Stempkovskaya, E
- Busneag, IC
- Domeyer, PR
- Gjorgjievski, D
- Hoffmann, K
- Ilkov, O
- Karathanos, VT
- Kirkovski, A
- Knezevic, S
- Korkmaz, BÇ
- Heleno, B
- Nessler, K
- Murauskiene, L
- López, NP
- Perjés, A
- Petek, D
- Petrazzuoli, F
- Petricek, G
- Seifert, B
- Serafini, A
- Sentker, T
- Tiili, P
- Torzsa, P
- Vaes, B
- van Pottebergh, G
- Vinker, S
- Astier-Peña, MP
- Gómez-Bravo, R
- Lingner, H
- Clinical Investigators
Unidades de investigação
Abstract
BackgroundMost COVID-19 patients were treated in primary health care (PHC) in Europe.ObjectivesTo demonstrate the scope of PHC workflow during the COVID-19 pandemic emphasising similarities and differences of patient's clinical pathways in Europe.MethodsDescriptive, cross-sectional study with data acquired through a semi-structured questionnaire in PHC in 30 European countries, created ad hoc and agreed upon among all researchers who participated in the study. GPs from each country answered the approved questionnaire. Main variable: PHC COVID-19 acute clinical pathway. All variables were collected from each country as of September 2020.ResultsCOVID-19 clinics in PHC facilities were organised in 8/30. Case detection and testing were performed in PHC in 27/30 countries. RT-PCR and lateral flow tests were performed in PHC in 23/30, free of charge with a medical prescription. Contact tracing was performed mainly by public health authorities. Mandatory isolation ranged from 5 to 14 days. Sick leave certification was given exclusively by GPs in 21/30 countries. Patient hotels or other resources to isolate patients were available in 12/30. Follow-up to monitor the symptoms and/or new complementary tests was made mainly by phone call (27/30). Chest X-ray and phlebotomy were performed in PHC in 18/30 and 23/30 countries, respectively. Oxygen and low-molecular-weight heparin were available in PHC (21/30).ConclusionIn Europe PHC participated in many steps to diagnose, treat and monitor COVID-19 patients. Differences among countries might be addressed at European level for the management of future pandemics.
Dados da publicação
- ISSN/ISSNe:
- 1381-4788, 1751-1402
- Tipo:
- Article
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
European Journal of General Practice Taylor and Francis Ltd.
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 10
Documentos
- Não há documentos
Filiações
Keywords
- COVID-19; Europe; patient care management; primary health care; standard of care; policy
Proyectos asociados
Digital maturity and its determinants in General Practice: a cross sectional study in 20 countries
Investigador Principal: Ana Luisa Fernandes Neves Soares
Estudo Clínico Académico . 2023
Citar a publicação
Ares S,Guisado M,Del Rio LR,Larrondo IG,Fitzgerald L,Adler L,Assenova R,Bakola M,Bayen S,Brutskaya E,Busneag IC,Domeyer PR,Gjorgjievski D,Hoffmann K,Ilkov O,Karathanos VT,Kirkovski A,Knezevic S,Korkmaz BÇ,Heleno B,Nessler K,Murauskiene L,Neves AL,López NP,Perjés A,Petek D,Petrazzuoli F,Petricek G,Seifert B,Serafini A,Sentker T,Tiili P,Torzsa P,Vaes B,van G,Vinker S,Astier MP,Gómez R,Lingner H,Clinical I. Clinical pathway of COVID-19 patients in primary health care in 30 European countries: Eurodata study. Eur. J. Gen. Pract. 2023. 29. (2):2182879. IF:3,400. (1).